Stay updated on Nivolumab in Resected Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.

Latest updates to the Nivolumab in Resected Esophageal Cancer Clinical Trial page
- Check7 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.3, indicating a version update to the page or its underlying template. It does not appear to modify core study content or participant information.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardized the Intervention/Treatment label, replacing the previous Intervention / Treatment. The page now also shows the recruitment status as 'No longer looking for participants', indicating that enrollment has ended.SummaryDifference0.1%

- Check28 days agoChange DetectedRevision: v3.5.5 is now shown in the page's revision history, replacing the previous Revision: v3.5.4.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates an updated version of the referenced document or page metadata.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page footer version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This reflects a site/version update and does not change the study details shown on the record.SummaryDifference0.0%

- Check78 days agoChange DetectedCollaborator name updated from Ono Pharmaceutical Co. Ltd to Ono Pharmaceutical Co., Ltd and the document revision advanced from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in Resected Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.